(Q7553347)

Sodium oxybate (English)

18 November 2016

chemical formula

C₄H₇NaO₃

1 reference

Sodium oxybate (English)

18 November 2016

canonical SMILES

C(CC(=O)[O-])CO.[Na+]

1 reference

medical condition treated

Sodium oxybate (English)

18 November 2016

1 reference

14 February 2018

1 reference

13 December 2016

chronic fatigue syndrome

1 reference

2 October 2018

fibromyalgia

1 reference

2 October 2018

insomnia

1 reference

2 October 2018

hypersomnia

1 reference

2 October 2018

sleep-wake disorder

1 reference

2 October 2018

narcolepsy

1 reference

significant drug interaction

2 October 2018

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

loxapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lormetazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alprazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

loxapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

imported from Wikimedia project

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category C

1 reference

1 reference

Medical Subject Headings

MeSH descriptor ID

D012978

15 March 2018

intravenous anesthetics

1 reference

InChI=1S/C4H8O3.Na/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1

Medical Subject Headings

15 March 2018

0 references

0 references

0 references

Identifiers

InChI

1 reference

Sodium oxybate (English)

18 November 2016

1 reference

Sodium oxybate (English)

18 November 2016

1 reference

sodium oxybate (English)

18 November 2016

1 reference

Xyrem (English)

18 November 2016

2 references

Sodium oxybate (English)

18 November 2016

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

SODIUM OXYBATE (English)

18 November 2016

1 reference

2 references

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

sodium oxybate (English)

ECHA Substance Infocard ID

18 November 2016

100.007.231

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.007.231

27 December 2018

Sodium 4-hydroxybutyrate (English)

quotation

CAS no.: 502-85-2 (English)

0 references

0 references

Sodium Oxybate

1 reference

Medical Subject Headings

14 March 2018

D02.241.081.114.937.700

0 references

0 references

1 reference

sodium oxybate (English)

18 November 2016

DrugBank ID

DB09072

1 reference

2 references

sodium oxybate (English)

18 November 2016

MedlinePlus drug identifier

0 references

1 reference

imported from Wikimedia project

sodium oxybate (English)

18 November 2016

0 references

1 reference

0 references

1 reference

sodium oxybate (English)